{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:21:18Z","timestamp":1760188878721},"reference-count":164,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1309\/mttm86ut1xfql7rv","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T20:33:14Z","timestamp":1176928394000},"page":"670-686","source":"Crossref","is-referenced-by-count":31,"title":["Cutaneous T-Cell and NK-Cell Lymphomas"],"prefix":"10.1093","volume":"127","author":[{"given":"Marsha C.","family":"Kinney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2007,5,1]]},"reference":[{"key":"E00001","unstructured":"Bouaziz JD, Bastuji-Garin S, Poszepczynska-Guigne E, et al. Relative frequency and survival of patients with primary cutaneous lymphomas: data from a single-centre study of 203 patients. <i>Br J Dermatol.<\/i> 2006;154:1206-1207."},{"key":"E00002","unstructured":"Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. <i>Blood.<\/i> 2005;105:3768-3785."},{"key":"E00003","unstructured":"Yamashita Y, Tsuzuki T, Nakayama A, et al. A case of natural killer\/T cell lymphoma of the subcutis resembling subcutaneous panniculitis-like T cell lymphoma. <i>Pathol Int.<\/i> 1999;49:241-246."},{"key":"E00004","unstructured":"LeBoit PE, Burg G, Weedon D, et al, eds. <i>Pathology and Genetics of Skin Tumours.<\/i> Lyon, France: IARC Press; 2006. <i>World Health Organization Classification of Tumours.<\/i>"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Slater DN. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. <i>Br J Dermatol.<\/i> 2005;153:874-880.","DOI":"10.1111\/j.1365-2133.2005.06905.x"},{"key":"E00006","unstructured":"Jaffe ES, Harris NL, Stein H, et al, eds. <i>Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.<\/i> Lyon, France: IARC Press; 2001. <i>World Health Organization Classification of Tumours.<\/i>"},{"key":"E00007","unstructured":"Burg G, Kempf W, Smoller B, et al. Mycosis fungoides. In: LeBoit P, Burg G, Weedon D, et al, eds. <i>Pathology and Genetics of Skin Tumours.<\/i> Lyon, France: IARC Press; 2006:169-174. <i>World Health Organization Classification of Tumours.<\/i>"},{"key":"E00008","unstructured":"Massone C, Kodama K, Kerl H, et al. Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients. <i>Am J Surg Pathol.<\/i> 2005;29:550-560."},{"key":"E00009","unstructured":"Kodama K, Fink-Puches R, Massone C, et al. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides. <i>J Am Acad Dermatol.<\/i> 2005;52:694-698."},{"key":"E00010","unstructured":"Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. <i>J Eur Acad Dermatol Venereol.<\/i> 2004;18:397-415."},{"key":"E00011","unstructured":"Smoller BR, Bishop K, Glusac E, et al. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. <i>Am J Surg Pathol.<\/i> 1995;19:1423-1430."},{"key":"E00012","unstructured":"Naraghi ZS, Seirafi H, Valikhani M, et al. Assessment of histologic criteria in the diagnosis of mycosis fungoides. <i>Int J Dermatol.<\/i> 2003;42:45-52."},{"key":"E00013","unstructured":"Santucci M, Biggeri A, Feller AC, et al, for the European Organization for Research and Treatment of Cancer. Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC Cutaneous Lymphoma Study Group investigation. <i>Am J Surg Pathol.<\/i> 2000;24:40-50."},{"key":"E00014","unstructured":"Lu D, Patel KA, Duvic M, et al. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas. <i>J Cutan Pathol.<\/i> 2002;29:465-472."},{"key":"E00015","doi-asserted-by":"crossref","unstructured":"Wallace ML, Smoller BR. Immunohistochemistry in diagnostic dermatopathology. <i>J Am Acad Dermatol.<\/i> 1996;34(2 pt 1):163-186.","DOI":"10.1016\/S0190-9622(96)80106-X"},{"key":"E00016","unstructured":"Chen M, Deng A, Crowson AN, et al. Assessment of T-cell clonality via T-cell receptor-gamma rearrangements in cutaneous T-cell-dominant infiltrates using polymerase chain reaction and single-stranded DNA conformational polymorphism assay. <i>Appl Immunohistochem Mol Morphol.<\/i> 2004;12:373-379."},{"key":"E00017","unstructured":"Wolff-Sneedorff A, Thomsen K, Secher L, et al. Gene rearrangement in positive patch tests. <i>Exp Dermatol.<\/i> 1995;4:322-326."},{"key":"E00018","unstructured":"Vega F, Luthra R, Medeiros LJ, et al. Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. <i>Blood.<\/i> .2002;100:3369-3373."},{"key":"E00019","unstructured":"Tokura Y, Jaffe ES, Sander CA. Cutaneous adult T-cell leukaemia\/lymphoma. In: LeBoit P, Burg G, Weedon D, et al, eds. <i>Pathology and Genetics of Skin Tumours.<\/i> Lyon, France: IARC Press; 2006:189-190. <i>World Health Organization Classification of Tumours.<\/i>"},{"key":"E00020","unstructured":"Johno M, Ohishi M, Kojo Y, et al. <i>Cutaneous Manifestations of Adult T-Cell Leukemia\/Lymphoma.<\/i> London, England: Taylor & Francis; Gann Monograph on Cancer Research. Vol 39. 1992:33-41."},{"key":"E00021","unstructured":"Leong AS, Sage RE, Kinnear GC, et al. Preferential epidermotropism in adult T-cell leukemia-lymphoma. <i>Am J Surg Pathol.<\/i> 1980;4:421-430."},{"key":"E00022","unstructured":"van Doorn R, Scheffer E, Willemze R. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. <i>Arch Dermatol.<\/i> 2002;138:191-198."},{"key":"E00023","unstructured":"Pereyo NG, Requena L, Galloway J, et al. Follicular mycosis fungoides: a clinicohistopathologic study. <i>J Am Acad Dermatol.<\/i> 1997;36:563-568."},{"key":"E00024","unstructured":"Kato N, Yasukawa K, Kimura K, et al. Anaplastic large-cell lymphoma associated with acquired ichthyosis. <i>J Am Acad Dermatol.<\/i> 2000;42:914-920."},{"key":"E00025","unstructured":"Hodak E, Amitay I, Feinmesser M, et al. Ichthyosiform mycosis fungoides: an atypical variant of cutaneous T-cell lymphoma. <i>J Am Acad Dermatol.<\/i> 2004;50:368-374."},{"key":"E00026","unstructured":"Gilliam AC, Lessin SR, Wilson DM, et al. Folliculotropic mycosis fungoides with large-cell transformation presenting as dissecting cellulitis of the scalp. <i>J Cutan Pathol.<\/i> 1997;24:169-175."},{"key":"E00027","unstructured":"Cerroni L, Fink-Puches R, El-Shabrawi-Caelen L, et al. Solitary skin lesions with histopathologic features of early mycosis fungoides. <i>Am J Dermatopathol.<\/i> 1999;21:518-524."},{"key":"E00028","unstructured":"Heald PW, Glusac EJ. Unilesional cutaneous T-cell lymphoma: clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant. <i>J Am Acad Dermatol.<\/i> 2000;42:283-285."},{"key":"E00029","unstructured":"Hodak E, Phenig E, Amichai B, et al. Unilesional mycosis fungoides: a study of seven cases. <i>Dermatology.<\/i> 2000;201:300-306."},{"key":"E00030","unstructured":"Oliver GF, Winkelmann RK. Unilesional mycosis fungoides: a distinct entity. <i>J Am Acad Dermatol.<\/i> 1989;20:63-70."},{"key":"E00031","unstructured":"Steffen C. Ketron-Goodman disease, Woringer-Kolopp disease, and pagetoid reticulosis. <i>Am J Dermatopathol.<\/i> 2005;27:68-85."},{"key":"E00032","unstructured":"Woringer MF, Kolopp P. Lesion erythemato-squameuse polycyclique de l'avant-bras evoluant depuis 6 ans chez un garconnet de 13 ans. <i>Ann Dermatol Syphilol.<\/i> 1939;10:945-958."},{"key":"E00033","unstructured":"Braun-Falco O, Marghescu S, Wolff HH. Pagetoide reticulosis: Woringer-Kolopp's disease [in German]. <i>Hautarzt.<\/i> 1973;24:11-21."},{"key":"E00034","unstructured":"Haghighi B, Smoller BR, LeBoit PE, et al. Pagetoid reticulosis (Woringer-Kolopp disease): an immunophenotypic, molecular, and clinicopathologic study. <i>Mod Pathol.<\/i> 2000;13:502-510."},{"key":"E00035","unstructured":"Harman M, Akdeniz S, Arslan A, et al. Mycosis fungoides with involvement of the oral cavity. <i>J Eur Acad Dermatol Venereol.<\/i> 1998;10:253-256."},{"key":"E00036","doi-asserted-by":"crossref","unstructured":"Sirois DA, Miller AS, Harwick RD, et al. Oral manifestations of cutaneous T-cell lymphoma: a report of eight cases. <i>Oral Surg Oral Med Oral Pathol.<\/i> 1993;<b>75<\/b>:700-705.","DOI":"10.1016\/0030-4220(93)90426-5"},{"key":"E00037","doi-asserted-by":"crossref","unstructured":"de la Fuente EG, Rodriguez-Peralto JL, Ortiz PL, et al. Oral involvement in mycosis fungoides: report of two cases and a literature review. <i>Acta Derm Venereol.<\/i> 2000;<b>80<\/b>:299-301.","DOI":"10.1080\/000155500750012234"},{"key":"E00038","doi-asserted-by":"crossref","unstructured":"Clarijs M, Poot F, Laka A, et al. Granulomatous slack skIn: treatment with extensive surgery and review of the literature. <i>Dermatology<\/i>. 2003;206:393-397.","DOI":"10.1159\/000069967"},{"key":"E00039","unstructured":"Camacho FM, Burg G, Moreno JC, et al. Granulomatous slack skin in childhood. <i>Pediatr Dermatol.<\/i> 1997;14:204-208."},{"key":"E00040","doi-asserted-by":"crossref","unstructured":"van Haselen CW, Toonstra J, van der Putte SJ, et al. Granulomatous slack skIn: report of three patients with an updated review of the literature. <i>Dermatology<\/i>. 1998;<b>196<\/b>:382-391.","DOI":"10.1159\/000017929"},{"key":"E00041","doi-asserted-by":"crossref","unstructured":"Tsang WY, Chan JK, Loo KT, et al. Granulomatous slack skin. <i>Histopathology<\/i>. 1994;25:49-55.","DOI":"10.1111\/j.1365-2559.1994.tb00597.x"},{"key":"E00042","unstructured":"Wada K, Maesawa C, Satoh T, et al. A case of primary cutaneous CD30+ T-cell lymphoproliferative disorder with features of granulomatous slack skin disease. <i>Br J Dermatol.<\/i> 2002;147:998-1002."},{"key":"E00043","doi-asserted-by":"crossref","unstructured":"Balus L, Manente L, Remotti D, et al. Granulomatous slack skIn: report of a case and review of the literature. <i>Am J Dermatopathol.<\/i> 1996;<b>18:<\/b>199-206.","DOI":"10.1097\/00000372-199604000-00015"},{"key":"E00044","doi-asserted-by":"crossref","unstructured":"von den Driesch P, Mielke V, Simon M Jr, et al. \"Granulomatous slack skin\": cutaneous elastolytic lymphoma [in German]. <i>Hautarzt<\/i>. 1994;45:861-865.","DOI":"10.1007\/s001050050187"},{"key":"E00045","doi-asserted-by":"crossref","unstructured":"Noto G, Pravata G, Miceli S, et al. Granulomatous slack skIn: report of a case associated with Hodgkin's disease and a review of the literature. <i>Br J Dermatol.<\/i> 1994;<b>131<\/b>:275-279.","DOI":"10.1111\/j.1365-2133.1994.tb08505.x"},{"key":"E00046","unstructured":"Vergier B, de Muret A, Beylot-Barry M, et al, for the French Study Group of Cutaneous Lymphomas. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. <i>Blood<\/i>. 2000;95:2212-2218."},{"key":"E00047","unstructured":"Salhany KE, Cousar JB, Greer JP, et al. Transformation of cutaneous T cell lymphoma to large cell lymphoma: a clinicopathologic and immunologic study. <i>Am J Pathol.<\/i> 1988;132:265-277."},{"key":"E00048","doi-asserted-by":"crossref","unstructured":"Diamandidou E, Colome-Grimmer M, Fayad L, et al. Transformation of mycosis fungoides\/S\u00e9zary syndrome: clinical characteristics and prognosis. <i>Blood<\/i>. 1998;92:1150-1159.","DOI":"10.1182\/blood.V92.4.1150"},{"key":"E00049","doi-asserted-by":"crossref","unstructured":"Lu D, Duvic M, Medeiros LJ, et al. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. <i>Am J Clin Pathol<\/i>. 2001;115:413-421.","DOI":"10.1309\/3N7P-J84L-JQ9K-G89R"},{"key":"E00050","doi-asserted-by":"crossref","unstructured":"Vermeer MH, Geelen FA, Kummer JA, et al. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. <i>Am J Pathol<\/i>. 1999;154:1203-1210.","DOI":"10.1016\/S0002-9440(10)65372-2"},{"key":"E00051","doi-asserted-by":"crossref","unstructured":"Kempf W. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. <i>J Cutan Pathol<\/i>. 2006;33(suppl 1):58-70.","DOI":"10.1111\/j.0303-6987.2006.00548.x"},{"key":"E00052","doi-asserted-by":"crossref","unstructured":"Bekkenk MW, Geelen FA, van Voorst Vader PC, et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. <i>Blood<\/i>. 2000;<b>95<\/b>:3653-3661.","DOI":"10.1182\/blood.V95.12.3653"},{"key":"E00053","unstructured":"Beljaards RC, Willemze R. The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas. <i>Br J Dermatol.<\/i> 1992;126:596-602."},{"key":"E00054","doi-asserted-by":"crossref","unstructured":"Wang HH, Myers T, Lach LJ, et al. Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis. <i>Cancer<\/i>. 1999;86:1240-1245.","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1240::AID-CNCR19>3.0.CO;2-X"},{"key":"E00055","unstructured":"Drews R, Samel A, Kadin ME. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin. <i>Semin Cutan Med Surg.<\/i> 2000;19:109-117."},{"key":"E00056","doi-asserted-by":"crossref","unstructured":"Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. <i>Blood<\/i>. 1985;66:848-858.","DOI":"10.1182\/blood.V66.4.848.bloodjournal664848"},{"key":"E00057","unstructured":"Natkunam Y, Smoller BR, Zehnder JL, et al. Aggressive cutaneous NK and NK-like T-cell lymphomas: clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. <i>Am J Surg Pathol.<\/i> 1999;23:571-581."},{"key":"E00058","unstructured":"Chang SE, Huh J, Choi JH, et al. Clinicopathological features of CD56+ nasal-type T\/natural killer cell lymphomas with lobular panniculitis. <i>Br J Dermatol.<\/i> 2000;142:924-930."},{"key":"E00059","doi-asserted-by":"crossref","unstructured":"Kobashi Y, Nakamura S, Sasajima Y, et al. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. <i>Histopathology<\/i>. 1996;28:111-120.","DOI":"10.1046\/j.1365-2559.1996.278324.x"},{"key":"E00060","unstructured":"Natkunam Y, Warnke RA, Haghighi B, et al. Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skIn: clinicopathologic, immunohistochemical and molecular analyses of seven cases. <i>J Cutan Pathol.<\/i> 2000;27:392-399."},{"key":"E00061","unstructured":"Herling M, Rassidakis GZ, Jones D, et al. Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria. <i>Hum Pathol.<\/i> 2004;35:455-459."},{"key":"E00062","unstructured":"Herbst H, Sander C, Tronnier M, et al. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. <i>Br J Dermatol.<\/i> 1997;137:680-686."},{"key":"E00063","unstructured":"Agarwal S, Remanathan U, Naresh KN. Epstein-Barr virus association and ALK gene expression in anaplastic large-cell lymphoma. <i>Hum Pathol.<\/i> 2002;33:146-152."},{"key":"E00064","unstructured":"Soler J, Bordes R, Ortuno F, et al. Aggressive natural killer cell leukaemia\/lymphoma in two patients with lethal midline granuloma. <i>Br J Haematol.<\/i> 1994;86:659-662."},{"key":"E00065","unstructured":"Chang SE, Lee SY, Choi JH, et al. Cutaneous dissemination of nasal NK\/T-cell lymphoma with bone marrow, liver and lung involvement. <i>Clin Exp Dermatol.<\/i> 2002;27:120-122."},{"key":"E00066","doi-asserted-by":"crossref","unstructured":"Imamura N, Kusunoki Y, Kawa-Ha K, et al. Aggressive natural killer cell leukaemia\/lymphoma: report of four cases and review of the literature: possible existence of a new clinical entity originating from the third lineage of lymphoid cells. <i>Br J Haematol.<\/i> 1990;<b>75<\/b>:49-59.","DOI":"10.1111\/j.1365-2141.1990.tb02615.x"},{"key":"E00067","unstructured":"Radonich MA, Lazova R, Bolognia J. Cutaneous natural killer\/T-cell lymphoma. <i>J Am Acad Dermatol.<\/i> 2002;46:451-456."},{"key":"E00068","unstructured":"Nava VE, Jaffe ES. The pathology of NK-cell lymphomas and leukemias. <i>Adv Anat Pathol.<\/i> 2005;12:27-34."},{"key":"E00069","doi-asserted-by":"crossref","unstructured":"Oshimi K, Kawa K, Nakamura S, et al. NK-cell neoplasms in Japan. <i>Hematology<\/i>. 2005;10:237-245.","DOI":"10.1080\/10245330400026162"},{"key":"E00070","doi-asserted-by":"crossref","unstructured":"Barrionuevo C, Anderson VM, Zevallos-Giampietri E, et al. Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. <i>Appl Immunohistochem Mol Morphol<\/i>. 2002;10:7-14.","DOI":"10.1097\/00129039-200203000-00002"},{"key":"E00071","unstructured":"Chen HH, Hsiao CH, Chiu HC. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. <i>Br J Dermatol.<\/i> 2002;147:587-591."},{"key":"E00072","unstructured":"Magana M, Sangueza P, Gil-Beristain J, et al. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma. <i>J Am Acad Dermatol.<\/i> 1998;38:574-579."},{"key":"E00073","doi-asserted-by":"crossref","unstructured":"Gentile TC, Uner AH, Hutchison RE, et al. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. <i>Blood<\/i>. 1994;84:2315-2321.","DOI":"10.1182\/blood.V84.7.2315.2315"},{"key":"E00074","unstructured":"Gonzalez CL, Medeiros LJ, Braziel RM, et al. T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome. <i>Am J Surg Pathol.<\/i> 1991;15:17-27."},{"key":"E00075","unstructured":"Jaffe ES, Burg G. Subcutaneous panniculitis-like T-cell lymphoma. In: LeBoit P, Burg G, Weedon D, et al, eds. <i>Pathology and Genetics of Skin Tumours<\/i>. Lyon, France: IARC Press; 2006:182-183. <i>World Health Organization Classification of Tumours<\/i>."},{"key":"E00076","unstructured":"Wick MR, Patterson JW. Cytophagic histiocytic panniculitis: a critical reappraisal. <i>Arch Dermatol.<\/i> 2000;136:922-924."},{"key":"E00077","doi-asserted-by":"crossref","unstructured":"Krenacs L, Smyth MJ, Bagdi E, et al. The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. <i>Blood<\/i>. 2003;101:3590-3593.","DOI":"10.1182\/blood-2002-09-2908"},{"key":"E00078","unstructured":"Sen F, Rassidakis GZ, Jones D, et al. Apoptosis and proliferation in subcutaneous panniculitis-like T-cell lymphoma. <i>Mod Pathol.<\/i> 2002;15:625-631."},{"key":"E00079","unstructured":"Salhany KE, Macon WR, Choi JK, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha\/beta and gamma\/delta subtypes. <i>Am J Surg Pathol.<\/i> 1998;22:881-893."},{"key":"E00080","unstructured":"Lozzi GP, Massone C, Citarella L, et al. Rimming of adipocytes by neoplastic lymphocytes: a histopathologic feature not restricted to subcutaneous T-cell lymphoma. <i>Am J Dermatopathol.<\/i> 2006;28:9-12."},{"key":"E00081","unstructured":"Massone C, Kodama K, Salmhofer W, et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. <i>J Cutan Pathol.<\/i> 2005;32:396-404."},{"key":"E00082","unstructured":"Arnulf B, Copie-Bergman C, Delfau-Larue M-H, et al. Nonhepatosplenic \u03b3\u03b4 T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization. <i>Blood<\/i>. 1998;91:1723-1731."},{"key":"E00083","unstructured":"Toro JR, Beaty M, Sorbara L, et al. \u03b3\u03b4 T-cell lymphoma of the skIn: a clinical, microscopic, and molecular study. <i>Arch Dermatol.<\/i> 2000;136:1024-1032."},{"key":"E00084","doi-asserted-by":"crossref","unstructured":"Toro JR, Liewehr DJ, Pabby N, et al. Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. <i>Blood<\/i>. 2003;101:3407-3412.","DOI":"10.1182\/blood-2002-05-1597"},{"key":"E00085","doi-asserted-by":"crossref","unstructured":"Munn SE, McGregor JM, Jones A, et al. Clinical and pathological heterogeneity in cutaneous gamma-delta T-cell lymphoma: a report of three cases and a review of the literature. <i>Br J Dermatol.<\/i> 1996;<b>135<\/b>:976-981.","DOI":"10.1046\/j.1365-2133.1996.d01-1106.x"},{"key":"E00086","doi-asserted-by":"crossref","unstructured":"de Wolf-Peeters C, Achten R. \u03b3\u03b4 T-cell lymphomas: a homogeneous entity? <i>Histopathology<\/i>. 2000;36:294-305.","DOI":"10.1046\/j.1365-2559.2000.00893.x"},{"key":"E00087","unstructured":"Massone C, Chott A, Metze D, et al. Subcutaneous, blastic natural killer (NK), NK\/T-cell, and other cytotoxic lymphomas of the skIn: a morphologic, immunophenotypic, and molecular study of 50 patients. <i>Am J Surg Pathol.<\/i> 2004;28:719-735."},{"key":"E00088","unstructured":"Ralfkiaer E, Willemze R, Meijer CJLM, et al. Primary cutaneous peripheral T-cell lymphoma, unspecified. In: LeBoit P, Burg G, Weedon D, et al, eds. <i>Pathology and Genetics of Skin Tumours<\/i>. Lyon, France: IARC Press; 2006;184-188. <i>World Health Organization Classification of Tumours.<\/i>"},{"key":"E00089","doi-asserted-by":"crossref","unstructured":"Wang H, Medeiros LJ, Jones D. Subcutaneous panniculitis-like T-cell lymphoma. <i>Clin Lymphoma<\/i>. 2002;3:181-183.","DOI":"10.1016\/S1526-9655(11)70265-2"},{"key":"E00090","unstructured":"Avinoach I, Halevy S, Argov S, et al. gamma\/delta T-cell lymphoma involving the subcutaneous tissue and associated with a hemophagocytic syndrome. <i>Am J Dermatopathol.<\/i> 1994;16:426-433."},{"key":"E00091","unstructured":"Ahmad E, Kingma DW, Jaffe ES, et al. Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow. <i>Cytometry B Clin Cytom.<\/i> 2005;67:6-12."},{"key":"E00092","unstructured":"Berti E, Cerri A, Cavicchini S, et al. Primary cutaneous gamma\/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis. <i>J Invest Dermatol.<\/i> 1991;96:718-723."},{"key":"E00093","unstructured":"Jones D, Vega F, Sarris AH, et al. CD4-CD8-\"double-negative\" cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course. <i>Am J Surg Pathol.<\/i> 2002;26:225-231."},{"key":"E00094","doi-asserted-by":"crossref","unstructured":"Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. <i>Blood<\/i>. 1993;81:2688-2695.","DOI":"10.1182\/blood.V81.10.2688.2688"},{"key":"E00095","doi-asserted-by":"crossref","unstructured":"Belhadj K, Reyes F, Farcet J-P, et al. Hepatosplenic \u03b3\u03b4 T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. <i>Blood<\/i>. 2003;<b>102<\/b>:4261-4269.","DOI":"10.1182\/blood-2003-05-1675"},{"key":"E00096","unstructured":"Kagami Y, Nakamura S, Suzuki R, et al. A nodal gamma\/delta T-cell lymphoma with an association of Epstein-Barr virus. <i>Am J Surg Pathol.<\/i> 1997;21:729-736."},{"key":"E00097","doi-asserted-by":"crossref","unstructured":"Ohshima K, Haraoka S, Harada N, et al. Hepatosplenic \u03b3\u03b4 T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules. <i>Histopathology<\/i>. 2000;36:127-135.","DOI":"10.1046\/j.1365-2559.2000.00804.x"},{"key":"E00098","unstructured":"Agnarsson BA, Vonderheid EC, Kadin ME. Cutaneous T cell lymphoma with suppressor\/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. <i>J Am Acad Dermatol.<\/i> 1990;22:569-577."},{"key":"E00099","unstructured":"Srivastava M, Rencic A, Nousari HC. A rapidly expanding ulcer: myelodysplastic syndrome-associated (paraneoplastic) pyoderma gangrenosum. <i>Arch Dermatol.<\/i> 2003;139:531-536."},{"key":"E00100","unstructured":"Srivastava MD, Alexander F, Tuthill RJ. Immunology of cutaneous vasculitis associated with both etanercept and infliximab. <i>Scand J Immunol.<\/i> 2005;61:329-336."},{"key":"E00101","unstructured":"Adams AE, Zwicker J, Curiel C, et al. Aggressive cutaneous T-cell lymphomas after TNFalpha blockade. <i>J Am Acad Dermatol.<\/i> 2004;51:660-662."},{"key":"E00102","unstructured":"Mahe E, Descamps V, Grossin M, et al. CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab. <i>Br J Dermatol.<\/i> 2003;149:170-173."},{"key":"E00103","doi-asserted-by":"crossref","unstructured":"Berthelot C, Cather J, Jones D, et al. Atypical CD8+ cutaneous T-cell lymphoma after immunomodulatory therapy. <i>Clin Lymphoma Myeloma<\/i>. 2006;6:329-332.","DOI":"10.3816\/CLM.2006.n.008"},{"key":"E00104","unstructured":"Magro CM, Crowson AN. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. <i>J Cutan Pathol.<\/i> 2003;30:1-10."},{"key":"E00105","unstructured":"Long D, Thiboutot DM, Majeski JT, et al. Interstitial granulomatous dermatitis with arthritis. <i>J Am Acad Dermatol.<\/i> 1996;34:957-961."},{"key":"E00106","doi-asserted-by":"crossref","unstructured":"Monterroso V, Bujan W, Jaramillo O, et al. Subcutaneous tissue involvement by T-cell lymphoma: a report of 2 cases. <i>Arch Dermatol.<\/i> 1996;<b>132<\/b>:1345-1350.","DOI":"10.1001\/archderm.132.11.1345"},{"key":"E00107","unstructured":"Berti E, Tomasini D, Vermeer MH, et al. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: a distinct clinicopathological entity with an aggressive clinical behavior. <i>Am J Pathol.<\/i> 1999;155:483-492."},{"key":"E00108","unstructured":"El-Shabrawi-Caelen L, Cerroni L, Medeiros LJ, et al. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype. <i>Am J Surg Pathol.<\/i> 2002;26:450-457."},{"key":"E00109","unstructured":"Smolle J, Torne R, Soyer HP, et al. Immunohistochemical classification of cutaneous pseudolymphomas: delineation of distinct patterns. <i>J Cutan Pathol.<\/i> 1990;17:149-159."},{"key":"E00110","unstructured":"Cerroni L, Goteri G. Differential diagnosis between cutaneous lymphoma and pseudolymphoma. <i>Anal Quant Cytol Histol.<\/i> 2003;25:191-198."},{"key":"E00111","doi-asserted-by":"crossref","unstructured":"Rijlaarsdam JU, Scheffer E, Meijer CJ, et al. Cutaneous pseudo-T-cell lymphomas: a clinicopathologic study of 20 patients. <i>Cancer<\/i>. 1992;69:717-724.","DOI":"10.1002\/1097-0142(19920201)69:3<717::AID-CNCR2820690319>3.0.CO;2-I"},{"key":"E00112","unstructured":"Magro CM, Crowson AN. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis. <i>Hum Pathol.<\/i> 1996;27:125-132."},{"key":"E00113","unstructured":"Magro CM, Crowson AN, Kovatich AJ, et al. Drug-induced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T cells. <i>Hum Pathol.<\/i> 2003;34:119-129."},{"key":"E00114","unstructured":"Cepeda LT, Pieretti M, Chapman SF, et al. CD30-positive atypical lymphoid cells in common non-neoplastic cutaneous infiltrates rich in neutrophils and eosinophils. <i>Am J Surg Pathol.<\/i> 2003;27:912-918."},{"key":"E00115","unstructured":"Rose C, Starostik P, Brocker EB. Infection with parapoxvirus induces CD30-positive cutaneous infiltrates in humans. <i>J Cutan Pathol.<\/i> 1999;26:520-522."},{"key":"E00116","unstructured":"Deng A, Harvey V, Sina B, et al. Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors. <i>Arch Dermatol.<\/i> 2006;142:198-202."},{"key":"E00117","unstructured":"Magro CM, Crowson AN, Schapiro BL. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. <i>J Cutan Pathol.<\/i> 1998;25:72-78."},{"key":"E00118","unstructured":"Mohan N, Edwards ET, Cupps TR, et al. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. <i>J Rheumatol.<\/i> 2004;31:1955-1958."},{"key":"E00119","doi-asserted-by":"crossref","unstructured":"Devos SA, Van Den Bossche N, De Vos M, et al. Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. <i>Dermatology<\/i>. 2003;206:388-390.","DOI":"10.1159\/000069965"},{"key":"E00120","doi-asserted-by":"crossref","unstructured":"Kadin ME, Sako D, Berliner N, et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. <i>Blood<\/i>. 1986;68:1042-1049.","DOI":"10.1182\/blood.V68.5.1042.1042"},{"key":"E00121","unstructured":"Beljaards RC, Meijer CJ, Scheffer E, et al. Prognostic significance of CD30 (Ki-1\/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origIn: a clinicopathologic and immunohistochemical study in 20 patients. <i>Am J Pathol.<\/i> 1989;135:1169-1178."},{"key":"E00122","doi-asserted-by":"crossref","unstructured":"Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis: a European multicenter study of 47 patients. <i>Cancer<\/i>. 1993;71:2097-2104.","DOI":"10.1002\/1097-0142(19930315)71:6<2097::AID-CNCR2820710626>3.0.CO;2-7"},{"key":"E00123","unstructured":"Paulli M, Berti E, Rosso R, et al. CD30\/Ki-1-positive lymphoproliferative disorders of the skIn: clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group. <i>J Clin Oncol.<\/i> 1995;13:1343-1354."},{"key":"E00124","doi-asserted-by":"crossref","unstructured":"Kumar S, Pittaluga S, Raffeld M, et al. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature. <i>Pediatr Dev Pathol.<\/i> 2005;<b>8<\/b>:52-60.","DOI":"10.1007\/s10024-004-8087-6"},{"key":"E00125","doi-asserted-by":"crossref","unstructured":"Fink-Puches R, Chott A, Ardigo M, et al. The spectrum of cutaneous lymphomas in patients less than 20 years of age. <i>Pediatr Dermatol<\/i>. 2004;21:525-533.","DOI":"10.1111\/j.0736-8046.2004.21500.x"},{"key":"E00126","unstructured":"Vergier B, Beylot-Barry M, Pulford K, et al. Statistical evaluation of diagnostic and prognostic features of CD30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. <i>Am J Surg Pathol.<\/i> 1998;22:1192-1202."},{"key":"E00127","unstructured":"Nijsten T, Curiel-Lewandrowski C, Kadin ME. Lymphomatoid papulosis in children: a retrospective cohort study of 35 cases. <i>Arch Dermatol.<\/i> 2004;140:306-312."},{"key":"E00128","unstructured":"Sioutos N, Kadin ME. Perivascular Ki-1 + lesions. <i>Int J Hematol.<\/i> 1992;55:275-279."},{"key":"E00129","doi-asserted-by":"crossref","unstructured":"Macgrogan G, Vergier B, Dubus P, et al. CD30-positive cutaneous large cell lymphomas: a comparative study of clinicopathologic and molecular features of 16 cases. <i>Am J Clin Pathol<\/i>. 1996;105:440-450.","DOI":"10.1093\/ajcp\/105.4.440"},{"key":"E00130","doi-asserted-by":"crossref","unstructured":"Mann KP, Hall B, Kamino H, et al. Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma. <i>Am J Surg Pathol<\/i>. 1995;19:407-416.","DOI":"10.1097\/00000478-199504000-00002"},{"key":"E00131","doi-asserted-by":"crossref","unstructured":"Jhala DN, Medeiros LJ, Lopez-Terrada D, et al. Neutrophilrich anaplastic large cell lymphoma of T-cell lineage: a report of two cases arising in HIV-positive patients. <i>Am J Clin Pathol.<\/i> 2000;<b>114<\/b>:478-482.","DOI":"10.1093\/ajcp\/114.3.478"},{"key":"E00132","unstructured":"Burg G, Kempf W, Kazakov DV, et al. Pyogenic lymphoma of the skIn: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma: clinicopathological study of four cases and review of the literature. <i>Br J Dermatol.<\/i> 2003;148:580-586."},{"key":"E00133","doi-asserted-by":"crossref","unstructured":"Lin JH, Lee JY. Primary cutaneous CD30 anaplastic large cell lymphoma with keratoacanthoma-like pseudocarcinomatous hyperplasia and marked eosinophilia and neutrophilia. <i>J Cutan Pathol<\/i>. 2004;31:458-461.","DOI":"10.1111\/j.0303-6987.2004.00204.x"},{"key":"E00134","unstructured":"El Shabrawi-Caelen L, Kerl H, Cerroni L. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. <i>Arch Dermatol.<\/i> 2004;140:441-447."},{"key":"E00135","doi-asserted-by":"crossref","unstructured":"Willemze R, Beljaards RC. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: a proposal for classification and guidelines for management and treatment. <i>J Am Acad Dermatol<\/i>. 1993;28:973-980.","DOI":"10.1016\/0190-9622(93)70140-O"},{"key":"E00136","unstructured":"ten Berge RL, Oudejans JJ, Ossenkoppele GJ, et al. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination. <i>J Clin Pathol.<\/i> 2000;53:445-450."},{"key":"E00137","unstructured":"DeCoteau JF, Butmarc JR, Kinney MC, et al. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. <i>Blood.<\/i> 1996;87:3437-3441."},{"key":"E00138","doi-asserted-by":"crossref","unstructured":"Sasaki K, Sugaya M, Fujita H, et al. A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation. <i>Br J Dermatol<\/i>. 2004;150:1202-1207.","DOI":"10.1111\/j.1365-2133.2004.05987.x"},{"key":"E00139","doi-asserted-by":"crossref","unstructured":"Bonzheim I, Geissinger E, Roth S, et al. Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. <i>Blood<\/i>. 2004;104:3358-3360.","DOI":"10.1182\/blood-2004-03-1037"},{"key":"E00140","unstructured":"Admirand JH, Rassidakis GZ, Abruzzo LV, et al. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma. <i>Mod Pathol.<\/i> 2004;17:954-961."},{"key":"E00141","unstructured":"Felgar RE, Salhany KE, Macon WR, et al. The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features. <i>Hum Pathol.<\/i> 1999;30:228-236."},{"key":"E00142","doi-asserted-by":"crossref","unstructured":"Boulland ML, Wechsler J, Bagot M, et al. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins. <i>Histopathology<\/i>. 2000;36:136-144.","DOI":"10.1046\/j.1365-2559.2000.00799.x"},{"key":"E00143","unstructured":"Nascimento AF, Pinkus JL, Pinkus GS. Clusterin, a marker for anaplastic large cell lymphoma: immunohistochemical profile in hematopoietic and nonhematopoietic malignant neoplasms. <i>Am J Clin Pathol.<\/i> 2004;121:709-717."},{"key":"E00144","unstructured":"Saffer H, Wahed A, Rassidakis GZ, et al. Clusterin expression in malignant lymphomas: a survey of 266 cases. <i>Mod Pathol.<\/i> 2002;15:1221-1226."},{"key":"E00145","unstructured":"Lae ME, Ahmed I, Macon WR. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma. <i>Am J Clin Pathol.<\/i> 2002;118:773-779."},{"key":"E00146","unstructured":"Suzuki R, Kagami Y, Takeuchi K, et al. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T\/null cell phenotype. <i>Blood<\/i>. 2000;96:2993-3000."},{"key":"E00147","unstructured":"Bekkenk MW, Jansen PM, Meijer CJ, et al. CD56+ hematological neoplasms presenting in the skIn: a retrospective analysis of 23 new cases and 130 cases from the literature. <i>Ann Oncol.<\/i> 2004;15:1097-1108."},{"key":"E00148","unstructured":"Magro CM, Crowson AN, Morrison C, et al. CD8+ lymphomatoid papulosis and its differential diagnosis. <i>Am J Clin Pathol.<\/i> 2006;125:490-501."},{"key":"E00149","doi-asserted-by":"crossref","unstructured":"de Bruin PC, Beljaards RC, van Heerde P, et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. <i>Histopathology<\/i>. 1993;23:127-135.","DOI":"10.1111\/j.1365-2559.1993.tb00470.x"},{"key":"E00150","unstructured":"Kadin ME, Naeem H, Kieffer D, et al. Differential expression of cutaneous lymphocyte antigen in lymphomatoid papulosis and lymphomas is a potential marker for diagnosis and tumor progression [abstract]. <i>J Invest Dermatol<\/i>. 2004;122:A30."},{"key":"E00151","unstructured":"Kempf W, Levi E, Kamarashev J, et al. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. <i>J Cutan Pathol.<\/i> 2002;29:295-300."},{"key":"E00152","unstructured":"Kadin ME, Levi E, Kempf W. Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand. <i>Ann N Y Acad Sci.<\/i> 2001;941:59-68."},{"key":"E00153","unstructured":"Basarab T, Fraser-Andrews EA, Orchard G, et al. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases. <i>Br J Dermatol.<\/i> 1998;139:630-638."},{"key":"E00154","doi-asserted-by":"crossref","unstructured":"Steinhoff M, Hummel M, Anagnostopoulos I, et al. Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin. <i>Blood<\/i>. 2002;100:578-584.","DOI":"10.1182\/blood-2001-12-0199"},{"key":"E00155","unstructured":"Kadin ME, Vonderheid EC, Sako D, et al. Clonal composition of T cells in lymphomatoid papulosis. <i>Am J Pathol.<\/i> 1987;126:13-17."},{"key":"E00156","unstructured":"Chott A, Vonderheid EC, Olbricht S, et al. The dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. <i>J Invest Dermatol.<\/i> 1996;106:696-700."},{"key":"E00157","unstructured":"Gellrich S, Wernicke M, Wilks A, et al. The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative). <i>J Invest Dermatol.<\/i> 2004;122:859-861."},{"key":"E00158","doi-asserted-by":"crossref","unstructured":"Coyne JD, Banerjee SS, Bromley M, et al. Post-transplant T-cell lymphoproliferative disorder\/T-cell lymphoma: a report of three cases of T-anaplastic large-cell lymphoma with cutaneous presentation and a review of the literature. <i>Histopathology<\/i>. 2004;<b>44<\/b>:387-393.","DOI":"10.1111\/j.1365-2559.2004.01847.x"},{"key":"E00159","unstructured":"Kaplan MA, Jacobson JO, Ferry JA, et al. T-cell lymphoma of the vulva in a renal allograft recipient with associated hemophagocytosis. <i>Am J Surg Pathol.<\/i> 1993;17:842-849."},{"key":"E00160","unstructured":"Pitman SD, Rowsell EH, Cao JD, et al. Anaplastic large cell lymphoma associated with Epstein-Barr virus following cardiac transplant. <i>Am J Surg Pathol.<\/i> 2004;28:410-415."},{"key":"E00161","doi-asserted-by":"crossref","unstructured":"Yurtsever H, Kempf W, Laeng RH. Posttransplant CD30+ anaplastic large cell lymphoma with skin and lymph node involvement. <i>Dermatology<\/i>. 2003;207:107-110.","DOI":"10.1159\/000070960"},{"key":"E00162","doi-asserted-by":"crossref","unstructured":"Kim HK, Jin SY, Lee NS, et al. Posttransplant primary cutaneous Ki-1 (CD30)+\/CD56+ anaplastic large cell lymphoma. <i>Arch Pathol Lab Med<\/i>. 2004;128:e96-e99.","DOI":"10.5858\/2004-128-e96-PPCKCA"},{"key":"E00163","unstructured":"Kohler S, Iwatsuki K, Jaffe ES, et al. Extranodal NK\/T-cell lymphoma, nasal-type. In: LeBoit P, Burg G, Weedon D, et al, eds. <i>Pathology and Genetics of Skin Tumours<\/i>. Lyon, France: IARC Press; 2006:191-192. <i>World Health Organization Classification of Tumours<\/i>."},{"key":"E00164","unstructured":"Mraz-Gernhard S, Natkunam Y, Hoppe RT, et al. Natural killer\/natural killer-like T-cell lymphoma, CD56+, presenting in the skIn: an increasingly recognized entity with an aggressive course. <i>J Clin Oncol.<\/i> 2001;19:2179-2188."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/127\/5\/670\/4987928\/ajcpath127-0670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T14:27:19Z","timestamp":1683815239000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/MTTM86UT1XFQL7RV"}},"subtitle":["The WHO-EORTC Classification and the Increasing Recognition of Specialized Tumor Types"],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":164,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,5,1]]},"published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1309\/MTTM86UT1XFQL7RV"],"URL":"https:\/\/doi.org\/10.1309\/mttm86ut1xfql7rv","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}